Market Access Focus Peregrine Market Access specializes in demonstrating the value of FDA-approved treatments to payers, presenting a clear opportunity to upsell expanded market access services to pharmaceutical and biotech clients seeking favorable reimbursement outcomes.

Growth Recognition Recognized as a fast-growing private company and a Great Place to Work, Peregrine can leverage this credibility to win business from mid-size and emerging life sciences firms looking for reputable, scalable market access partners.

Strategic Partnerships Recent integration with BlackRock for credit trading protocols via MarketAxess and Aladdin OEMS signals potential for cross-sell of value modeling, reimbursement solutions, and communications services to clients seeking integrated financial and access strategies.

Leadership Expansion Multiple leadership promotions and new hires in 2023 indicate an expanding service footprint and potential for targeted opportunities in account services, value communications, and strategic consulting with growing client portfolios.

Regional Footprint Headquartered in New York with a Santa Monica office, Peregrine’s national reach supports targeting geographically diverse life sciences companies and payer environments, enabling region-specific market access programs and publications initiatives.